Latest NewsApr 29, 2025HiFiBiO Therapeutics to Present Preclinical Data for A Novel Immunology Antibody at the 2025 Annual Meeting of the Clinical Immunology Society All Filter By: Year20252024202320222021202020192018201720162015Jul 3, 2020HFB301001, a novel OX40 agonistic antibody with a unique pharmacological profile and innovative biomarker strategyJun 22, 2020HiFiBiO Therapeutics Presents Three Novel Immuno-Oncology Programs at 2020 AACR Virtual Annual Meeting IIMay 15, 2020HiFiBiO Therapeutics Unveils Several Novel Antibodies Showing Promise to Be Precision Immunotherapies for Cancer PatientsMar 30, 2020Droplet Microfluidic Screening and Sequencing Can Vastly Expand the Universe of New Antibody TherapeuticsJan 11, 2020Biotechs Build on Single-cell Analytics for Drug R&D, as Human Cell Atlas is Mapped< 1 … 10 11 12 13 14 … 17 >
